Allient (NASDAQ:ALNT - Get Free Report) had its target price decreased by JPMorgan Chase & Co. from $120.00 to $110.00 in a note issued to investors on Friday, Benzinga reports. The brokerage currently has a "neutral" rating on the stock. JPMorgan Chase & Co.'s price objective would suggest a potential upside of 35.27% from the stock's current price.
Several other research analysts also recently weighed in on ALNT. Wall Street Zen upgraded Allient from a "buy" rating to a "strong-buy" rating in a research note on Saturday. Zacks Research cut Allient from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, October 6th. Finally, Weiss Ratings downgraded shares of Allient from a "buy (b)" rating to a "hold (c+)" rating in a report on Monday, October 26th. Three analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $82.33.
View Our Latest Report on ALNT
Allient Stock Performance
NASDAQ ALNT opened at $81.32 on Friday. The company has a current ratio of 3.49, a quick ratio of 1.99 and a debt-to-equity ratio of 0.53. The business has a fifty day simple moving average of $98.64 and a 200 day simple moving average of $82.89. Allient has a 12 month low of $48.12 and a 12 month high of $121.42. The firm has a market capitalization of $1.38 billion, a P/E ratio of 36.63 and a beta of 1.62.
Allient (NASDAQ:ALNT - Get Free Report) last announced its earnings results on Wednesday, November 4th. The company reported $1.07 earnings per share for the quarter, topping analysts' consensus estimates of $0.74 by $0.33. The firm had revenue of $164.40 million for the quarter, compared to the consensus estimate of $155.25 million. Allient had a return on equity of 15.80% and a net margin of 6.24%. On average, analysts predict that Allient will post 2.72 EPS for the current fiscal year.
Hedge Funds Weigh In On Allient
A number of institutional investors have recently added to or reduced their stakes in the business. Aberdeen Group plc bought a new stake in shares of Allient in the 3rd quarter worth approximately $2,991,000. Russell Investments Group Ltd. grew its holdings in shares of Allient by 26.2% during the 3rd quarter. Russell Investments Group Ltd. now owns 49,237 shares of the company's stock valued at $5,495,000 after purchasing an additional 10,216 shares during the last quarter. Lisanti Capital Growth LLC grew its holdings in shares of Allient by 78.6% during the 3rd quarter. Lisanti Capital Growth LLC now owns 55,170 shares of the company's stock valued at $6,157,000 after purchasing an additional 24,280 shares during the last quarter. Ethic Inc. bought a new position in shares of Allient during the 3rd quarter valued at $363,000. Finally, Kornitzer Capital Management Inc. KS raised its position in Allient by 16.9% in the 3rd quarter. Kornitzer Capital Management Inc. KS now owns 59,059 shares of the company's stock worth $6,591,000 after purchasing an additional 8,534 shares during the period. 61.57% of the stock is currently owned by institutional investors.
Allient Company Profile
(
Get Free Report)
Allient Inc NASDAQ: ALNT designs and manufactures precision and engineered products that control motion, power, and electromagnetic energy. Its portfolio includes motors, motion-control systems, electronic controls, power electronics, magnetic components, and related assemblies used in demanding industrial applications.
The company serves customers in markets such as medical equipment, aerospace and defense, industrial automation, robotics, transportation, and other specialized equipment industries.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Allient, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allient wasn't on the list.
While Allient currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.